CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $3.01M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.19M | |
| 2 | +$57.6K | |
| 3 | +$30K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.71K |
Top Sellers
| 1 | -$85.9K | |
| 2 | -$35K | |
| 3 | -$17K | |
| 4 |
BlackRock
New York
|
-$15.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$740 |